$4.080
+0.324 (+7.94%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
PRLD 相似圖表分析預測
Alphio's PRLD stock price prediction model matches the current Prelude Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.09 (+0.35%). The 1-week path is $4.03 (-1.24%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Prelude Therapeutics Inc 股票嗎?
Prelude Therapeutics Inc is a good buy right now due to its current price of $3.84, which is significantly below the analyst price target of $12, indicating a potential upside of over 200%. Additionally, the stock has shown a year-to-date change of +40.66% and a one-year change of +118.18%, reflecting strong momentum. The main risk is the negative earnings per share (EPS) of -0.14 expected for the next quarter, which indicates ongoing financial challenges.
PRLD 股價於 Wednesday 收在 $4.08,此前上漲 +7.94%
Prelude Therapeutics Inc (PRLD) last closed at $4.0799999, gaining +7.94%. These facts feed the 1-day and 1-week PRLD price prediction above.
預測驅動因素
Prelude Therapeutics Inc(PRLD)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 PRLD 最接近的股票,依相似度排序。
PRLD 季節性分析
Historically the probability of a positive November return for PRLD is 50.00%. August offers the highest probability of a positive month at 71.88%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
PRLD 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Nov 2026 | $0.76 | $0.83 | $0.88 | -79.62% |
| Dec 2026 | $0.93 | $0.97 | $1.00 | -76.18% |
2026 年,Prelude Therapeutics Inc(PRLD)預計區間為 $0.76 至 $1.00。
Prelude Therapeutics Inc 2026 年月度預測
2026 年 Nov,Prelude Therapeutics Inc 預計均價 $0.83,最低 $0.76,最高 $0.88。
2026 年 Dec,Prelude Therapeutics Inc 預計均價 $0.97,最低 $0.93,最高 $1.00。
相關文章
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。